









市場
/
株式
/
nasdaq-asrt
/

Assertio Holdings Inc

ASRT

0.720USD

+0.008+1.15%

終値 12/19, 16:00（ET）15分遅れの株価

69.30M時価総額

損失額直近12ヶ月PER



Assertio Holdings Inc

0.720

+0.008+1.15%

概要企業名金融分析

概要

企業名

金融

分析

詳細情報 Assertio Holdings Inc 企業名

Assertio Holdings, Inc. is a pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through the acquisition or licensing of approved products. Its commercial capabilities include marketing through both a sales force and an omni-channel promotion model, market access through payor contracting, and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, and CAMBIA (diclofenac potassium for oral solution). INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID). Otrexup is a once weekly single-dose auto-injector containing methotrexate.

Assertio Holdings Incの企業情報



企業コードASRT

会社名Assertio Holdings Inc

上場日Feb 12, 1997

最高経営責任者「CEO」Reisenauer (Mark L)

従業員数58

証券種類Ordinary Share

決算期末Feb 12

本社所在地100 S. Saunders Road

都市LAKE FOREST

証券取引所NASDAQ OMX - NASDAQ BASIC

国United States of America

郵便番号60045

電話番号12244197106

ウェブサイトhttps://www.assertiotx.com/

企業コードASRT

上場日Feb 12, 1997

最高経営責任者「CEO」Reisenauer (Mark L)

Assertio Holdings Incの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Ajay Patel

Chief Financial Officer, Executive Vice President

196.85K

+12.05%

Mr. Paul Schwichtenberg

President, Chief Operating Officer

167.52K

+14.47%

Mr. Sam Schlessinger

Executive Vice President, General Counsel

156.13K

+17.33%

Mr. David Matthew Stark

Independent Director

98.54K

-8.33%

Mr. William T. Mckee

Independent Director

97.28K

+123.48%

Mr. Mark L. Reisenauer

Chief Executive Officer, Director

53.75K

Ms. Heather L. Mason

Independent Chairman of the Board

Mr. Sigurd C. (Sig) Kirk

Independent Director

Mr. Sravan K. Emany

Independent Director

Ms. Mary E Pietryga

Executive Vice President, Chief Commercial Officer

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Ajay Patel

Chief Financial Officer, Executive Vice President

196.85K

+12.05%

Mr. Paul Schwichtenberg

President, Chief Operating Officer

167.52K

+14.47%

Mr. Sam Schlessinger

Executive Vice President, General Counsel

156.13K

+17.33%

Mr. David Matthew Stark

Independent Director

98.54K

-8.33%

Mr. William T. Mckee

Independent Director

97.28K

+123.48%

Mr. Mark L. Reisenauer

Chief Executive Officer, Director

53.75K

収益内訳

通貨: USD更新時刻: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

ROLVEDON

16.13M

55.19%

other

4.44M

15.20%

Sympazan

3.24M

11.10%

INDOCIN products

3.03M

10.38%

SPRIX Nasal Spray

1.98M

6.76%

Royalties and milestone revenue

400.00K

1.37%

地域別USD

会社名

収益

比率

United States

29.22M

100.00%

事業別

地域別

事業別USD

会社名

収益

比率

ROLVEDON

16.13M

55.19%

other

4.44M

15.20%

Sympazan

3.24M

11.10%

INDOCIN products

3.03M

10.38%

SPRIX Nasal Spray

1.98M

6.76%

Royalties and milestone revenue

400.00K

1.37%

株主

更新時刻: Sat, Nov 8

株主統計

種類

株主統計

比率

Nantahala Capital Management, LLC

9.15%

The Vanguard Group, Inc.

4.60%

Renaissance Technologies LLC

3.06%

BlackRock Institutional Trust Company, N.A.

1.42%

Geode Capital Management, L.L.C.

1.06%

他の

80.71%

株主統計

比率

Nantahala Capital Management, LLC

9.15%

The Vanguard Group, Inc.

4.60%

Renaissance Technologies LLC

3.06%

BlackRock Institutional Trust Company, N.A.

1.42%

Geode Capital Management, L.L.C.

1.06%

他の

80.71%

種類

株主統計

比率

Hedge Fund

14.41%

Investment Advisor

9.48%

Investment Advisor/Hedge Fund

3.17%

Individual Investor

2.60%

Research Firm

0.09%

他の

70.25%

機関投資家保有株



更新時刻: Mon, Dec 8

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q4

224

26.13M

41.62%

2025Q3

272

26.13M

50.34%

+166.65K

2025Q2

302

25.96M

57.74%

-170.79K

2025Q1

322

26.13M

60.78%

-32.08M

2024Q4

324

28.59M

62.27%

-1.80M

2024Q3

317

30.58M

67.93%

-6.52M

2024Q2

313

38.50M

75.68%

-8.13M

2024Q1

304

45.57M

70.80%

-21.77M

2023Q4

296

48.05M

61.35%

+410.44K

2023Q3

284

47.86M

41.05%

+12.38M

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

Nantahala Capital Management, LLC

8.81M

9.15%

+370.31K

+4.39%

Jun 30, 2025

The Vanguard Group, Inc.

4.38M

4.56%

Jun 30, 2025

Renaissance Technologies LLC

2.82M

2.93%

+117.69K

+4.35%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

1.37M

1.43%

-11.56K

-0.83%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.02M

1.06%

-86.31K

-7.79%

Jun 30, 2025

Two Sigma Investments, LP

867.90K

0.9%

-357.19K

-29.16%

Jun 30, 2025

CM Management, LLC

724.38K

0.75%

+249.38K

+52.50%

Jun 30, 2025

Polen Capital Management, LLC

651.61K

0.68%

-129.46K

-16.57%

Sep 30, 2024

Peisert (Daniel A)

607.46K

0.63%

Mar 13, 2025

Millennium Management LLC

694.52K

0.72%

-90.05K

-11.48%

Jun 30, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 0.00 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

データなし

株式分割



日付

種類

比率

May 17, 2021

Merger

4→1

May 17, 2021

Merger

4→1

May 17, 2021

Merger

4→1

May 17, 2021

Merger

4→1

日付

種類

比率

May 17, 2021

Merger

4→1

May 17, 2021

Merger

4→1

May 17, 2021

Merger

4→1

May 17, 2021

Merger

4→1

よくある質問

Assertio Holdings Incの上位5名の株主は誰ですか？



Assertio Holdings Incの上位5名の株主は以下のとおりです。
Nantahala Capital Management, LLCは8.81M株を保有しており、これは全体の9.15%に相当します。
The Vanguard Group, Inc.は4.38M株を保有しており、これは全体の4.56%に相当します。
Renaissance Technologies LLCは2.82M株を保有しており、これは全体の2.93%に相当します。
BlackRock Institutional Trust Company, N.A.は1.37M株を保有しており、これは全体の1.43%に相当します。
Geode Capital Management, L.L.C.は1.02M株を保有しており、これは全体の1.06%に相当します。